Damora Therapeutics, Inc. (DMRA) Balance Sheet
DMRA balance sheet, 2025
December 31, 2025 · U.S. dollars$260.5M assets = $20.1M liabilities + $240.4M equity
Both columns are drawn to the same scale: what DMRA owns equals what it owes plus shareholders’ equity. Hover a block for its value.
DMRA financial health
Descriptive bands, not a rating. Fiscal 2025.
DMRA balance sheet trends, 2018–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $35.1M2018 | $260.5M2025 | +33.2%/yr | |
| Total liabilities | $4.4M2018 | $20.1M2025 | +24.1%/yr | |
| Shareholders’ equity | $30.7M2018 | $240.4M2025 | +34.2%/yr | |
| Cash & short-term investments | $31.0M2018 | $257.6M2025 | +35.3%/yr | |
| Total debt | $298,0002019 | $68,0002025 | −21.8%/yr | |
| Net cash (debt) | $11.0M2019 | $257.6M2025 | +$246.6M | |
| Working capital | $30.5M2018 | $240.4M2025 | +$209.8M | |
| Debt / equity | 0.012019 | 0.002025 | −0.01 |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
DMRA assets
DMRA liabilities and equity
DMRA debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
DMRA balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & short-term investments | $257.6M | $14.2M | $33.2M | $60.2M | $100.2M | $163.6M | $11.3M | $31.0M |
| Cash & equivalents | $257.6M | $14.2M | $21.5M | $32.8M | $62.6M | $163.6M | $11.3M | $31.0M |
| Short-term investments | — | $0 | $11.7M | $27.4M | $37.6M | — | — | — |
| Receivables | $899,000 | $881,000 | $1.7M | $1.4M | $2.3M | $2.2M | $41.1M | $989,000 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other current assets | $1.9M | $1.8M | $1.9M | $2.3M | $7.6M | $3.5M | $3.7M | $3.0M |
| Total current assets | $260.4M | $16.8M | $36.8M | $63.9M | $110.1M | $169.3M | $56.1M | $35.0M |
| Property, plant & equipment (net) | $104,000 | $130,000 | $325,000 | $1.2M | $1.0M | $885,000 | $298,000 | $0 |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $5.8M | $9.0M | $0 | $0 | $0 |
| Other non-current assets | $0 | $163,000 | $1.1M | $2.3M | $2.0M | $1.4M | $231,000 | $144,000 |
| Total assets | $260.5M | $17.1M | $38.2M | $73.2M | $122.2M | $171.6M | $56.6M | $35.1M |
| Liabilities | ||||||||
| Accounts payable | $444,000 | $377,000 | $1.7M | $3.4M | $1.5M | $2.9M | $3.3M | $1.4M |
| Short-term debt | $15,000 | $12,000 | $183,000 | $476,000 | $399,000 | $374,000 | $87,000 | — |
| Total current liabilities | $20.1M | $1.2M | $5.8M | $11.1M | $4.5M | $5.6M | $7.9M | $4.4M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | $68,000 | $73,000 | $249,000 | $804,000 | $847,000 | — | — | — |
| Other long-term liabilities | $81,000 | $1.5M | $65,999 | $328,000 | $448,000 | $541,000 | $211,000 | $0 |
| Total liabilities | $20.1M | $2.7M | $5.9M | $11.4M | $5.0M | $6.1M | $8.1M | $4.4M |
| Shareholders' equity | ||||||||
| Retained earnings (deficit) | −$487.4M | −$277.5M | −$256.1M | −$217.7M | −$156.1M | −$104.4M | −$69.5M | −$33.0M |
| Accumulated other comprehensive income | $802,000 | $97,000 | $380,000 | −$244,000 | −$320,000 | $674,000 | −$2.5M | −$1.6M |
| Total shareholders' equity | $240.4M | $14.5M | $32.3M | $61.8M | $117.2M | $165.5M | $48.5M | $30.7M |
| Key figures | ||||||||
| Total debt | $68,000 | $1.4M | $249,000 | $804,000 | $847,000 | $915,000 | $298,000 | — |
| Net cash (debt) | $257.6M | $12.7M | $32.9M | $59.4M | $99.3M | $162.7M | $11.0M | — |
| Working capital | $240.4M | $15.6M | $30.9M | $52.8M | $105.6M | $163.7M | $48.2M | $30.5M |
| Tangible book value | $240.4M | $14.5M | $32.3M | $61.8M | $117.2M | $165.5M | $48.5M | $30.7M |
| Current ratio | 12.98 | 14.07 | 6.31 | 5.75 | 24.23 | 30.42 | 7.07 | 7.87 |
| Quick ratio | 12.88 | 12.58 | 5.98 | 5.55 | 22.55 | 29.79 | 6.61 | 7.20 |
| Debt / equity | 0.00 | 0.10 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | — |
| Equity / assets | 92.3% | 84.5% | 84.6% | 84.4% | 95.9% | 96.4% | 85.6% | 87.3% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $540.5M | $532.9M | $257.6M | $7.6M | $10.2M | $11.9M | $14.2M | $19.7M | $22.9M | $27.2M | $33.2M | $44.2M |
| Cash & equivalents | $540.5M | $532.9M | $257.6M | $7.6M | $10.2M | $11.9M | $14.2M | $19.7M | $22.9M | $21.1M | $21.5M | $23.1M |
| Short-term investments | — | — | — | — | — | — | $0 | $0 | — | $6.1M | $11.7M | $21.1M |
| Receivables | $880,000 | $894,000 | $899,000 | $992,000 | $988,000 | $917,000 | $881,000 | $1.2M | $1.7M | $1.7M | $1.7M | $1.2M |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other current assets | $2.2M | $1.6M | $1.9M | $1.2M | $350,000 | $543,000 | $1.8M | $295,000 | $585,000 | $1.7M | $1.9M | $1.7M |
| Total current assets | $543.6M | $535.4M | $260.4M | $9.8M | $11.5M | $13.4M | $16.8M | $21.2M | $25.2M | $30.5M | $36.8M | $47.1M |
| Property, plant & equipment (net) | $0 | $0 | $104,000 | $113,000 | $122,000 | $125,000 | $130,000 | $94,000 | $143,000 | $225,000 | $325,000 | $578,000 |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $48,000 | $34,000 | $0 | $837,000 | $2.0M | $1.8M | $163,000 | $2.1M | $2.0M | $1.7M | $1.1M | $2.4M |
| Total assets | $543.6M | $535.4M | $260.5M | $10.7M | $13.7M | $15.4M | $17.1M | $23.4M | $27.3M | $32.5M | $38.2M | $50.0M |
| Liabilities | ||||||||||||
| Accounts payable | $3.5M | $819,000 | $444,000 | $520,000 | $756,000 | $354,000 | $377,000 | $503,000 | $724,000 | $1.7M | $1.7M | $4.5M |
| Short-term debt | — | — | $15,000 | $15,000 | $15,000 | $13,000 | $12,000 | $32,000 | $77,000 | $155,000 | $183,000 | $352,000 |
| Total current liabilities | $27.6M | $23.8M | $20.1M | $2.6M | $2.6M | $1.6M | $1.2M | $2.4M | $3.7M | $4.3M | $5.8M | $12.6M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | — | — | $68,000 | $72,000 | $75,000 | $73,000 | $73,000 | $32,000 | — | — | — | — |
| Other long-term liabilities | $27,000 | $1.4M | $81,000 | $1.4M | $1.4M | $1.5M | $1.5M | $0 | $0 | $0 | $65,999 | $112,000 |
| Total liabilities | $27.6M | $25.2M | $20.1M | $4.1M | $4.1M | $3.0M | $2.7M | $2.4M | $3.7M | $4.3M | $5.9M | $12.7M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $1,000 | $1,000 | — | — | — | — | — | — | — | — | — | — |
| Retained earnings (deficit) | −$546.3M | −$515.1M | −$487.4M | −$286.6M | −$283.5M | −$280.1M | −$277.5M | −$270.8M | −$266.9M | −$261.6M | −$256.1M | −$249.6M |
| Accumulated other comprehensive income | $732,000 | $754,000 | $802,000 | $823,000 | $809,000 | $300,000 | $97,000 | $665,000 | $197,000 | $326,000 | $380,000 | $46,000 |
| Total shareholders' equity | $516.1M | $510.3M | $240.4M | $6.7M | $9.6M | $12.3M | $14.5M | $20.9M | $23.6M | $28.2M | $32.3M | $37.4M |
| Key figures | ||||||||||||
| Total debt | — | $1.3M | $68,000 | $1.4M | $1.4M | $1.4M | $1.4M | $32,000 | $77,000 | $155,000 | $249,000 | $464,000 |
| Net cash (debt) | — | $531.6M | $257.6M | $6.2M | $8.8M | $10.5M | $12.7M | $19.6M | $22.8M | $27.0M | $32.9M | $43.7M |
| Working capital | $516.0M | $511.6M | $240.4M | $7.2M | $8.9M | $11.8M | $15.6M | $18.7M | $21.5M | $26.2M | $30.9M | $34.5M |
| Tangible book value | $516.1M | $510.3M | $240.4M | $6.7M | $9.6M | $12.3M | $14.5M | $20.9M | $23.6M | $28.2M | $32.3M | $37.4M |
| Book value per share | $8.44 | $14.88 | — | — | — | — | — | — | — | — | — | — |
| Shares outstanding | 61.1M | 34.3M | — | — | — | — | — | — | — | — | — | — |
| Current ratio | 19.73 | 22.48 | 12.98 | 3.73 | 4.39 | 8.64 | 14.07 | 8.68 | 6.79 | 7.07 | 6.31 | 3.75 |
| Quick ratio | 19.65 | 22.42 | 12.88 | 3.28 | 4.26 | 8.29 | 12.58 | 8.56 | 6.63 | 6.69 | 5.98 | 3.61 |
| Debt / equity | — | 0.00 | 0.00 | 0.21 | 0.15 | 0.12 | 0.10 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 |
| Equity / assets | 94.9% | 95.3% | 92.3% | 62.1% | 70.2% | 80.4% | 84.5% | 89.6% | 86.4% | 86.7% | 84.6% | 74.7% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed December 31, 2025); data from EODHD.
DMRA financial position
At the end of fiscal 2025 (December 31, 2025), Damora Therapeutics had total assets of $260.5 million (up 1,420.7% from a year earlier), total liabilities of $20.1 million and shareholders' equity of $240.4 million. It held $257.6 million in cash and short-term investments against $0.1 million of debt, a net cash position of $257.6 million. Its current ratio was 12.98. In the latest quarter (ended June 30, 2026) total assets were $543.6 million and equity $516.1 million.
Related: DMRA income statement, DMRA cash flow statement, DMRA key metrics. See the DMRA stock overview for the latest quote and news.
DMRA balance sheet FAQ
What are Damora Therapeutics's total assets?
Damora Therapeutics reported total assets of $260.5 million at the end of fiscal 2025 (December 31, 2025), compared with $17.1 million a year earlier.
How much debt does Damora Therapeutics have?
Damora Therapeutics had $0.1 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.00.
How much cash does Damora Therapeutics have?
Damora Therapeutics held $257.6 million in cash and short-term investments at the end of fiscal 2025; with $0.1 million of debt that is net cash of $257.6 million.
What is Damora Therapeutics's book value?
Damora Therapeutics's shareholders' equity (book value) was $240.4 million at the end of fiscal 2025.
What is Damora Therapeutics's current ratio?
Damora Therapeutics had current assets of $260.4 million and current liabilities of $20.1 million, a current ratio of 12.98 (it can cover its short-term obligations).